BV Cyclotron VU

BV Cyclotron VU is a company that specializes in the production of radiopharmaceuticals and radionuclides used in imaging techniques such as Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT). The company traces its origins back to 1964 when a Philips 28 MeV AVF cyclotron became operational at the VU University in Amsterdam, Netherlands, marking the beginning of nuclear physics research at the university. After the Dutch government decided to discontinue the use of particle accelerators in the country in 1986, a group of engineers founded BV Cyclotron VU in 1987 to continue the operation of the cyclotron.

BV Cyclotron VU operated three cyclotrons and various GMP production units from the Mathematics and Nature building of VU University to produce its radiopharmaceuticals and GMP radionuclides. Recently, the company has relocated to the Amsterdam UMC Imaging Center, a unique facility that combines sustainable state-of-the-art imaging techniques, tracer development facilities, and experts from various disciplines focused on patient care, research, and development.

The company's three new IBA Cyclone Kiubes offer the highest production capacity ever reached with an 18 MeV cyclotron, and it has the latest GMP hotlabs, making it one of the best-equipped centers for the production of radiopharmaceuticals in the Benelux region and one of the first commercial manufacturers of GMP-compliant Zirconium-89 globally. With the support of BV Cyclotron VU, the Amsterdam UMC Imaging Center aims to contribute to the development of new tracers and the testing of new therapies for leading international biotech and pharmaceutical companies.